Danaher (DHR) – Research Analysts’ Weekly Ratings Updates

A number of research firms have changed their ratings and price targets for Danaher (NYSE: DHR):

• 4/14/2026 – Danaher had its price target lowered by Barclays PLC from $250.00 to $230.00. They now have an “overweight” rating on the stock.
• 4/13/2026 – Danaher had its price target lowered by TD Cowen from $270.00 to $245.00. They now have a “buy” rating on the stock.
• 4/13/2026 – Danaher had its price target lowered by The Goldman Sachs Group, Inc. from $265.00 to $230.00. They now have a “buy” rating on the stock.
• 4/8/2026 – Danaher had its price target lowered by Jefferies Financial Group Inc. from $265.00 to $240.00. They now have a “buy” rating on the stock.
• 4/8/2026 – Danaher had its price target lowered by Wolfe Research from $260.00 to $230.00. They now have an “outperform” rating on the stock.
• 4/6/2026 – Danaher had its price target lowered by Evercore Inc from $254.00 to $225.00. They now have an “outperform” rating on the stock.
• 3/27/2026 – Danaher had its “hold (c)” rating reaffirmed by Weiss Ratings.

Danaher Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Friday, March 27th. This represents a $1.60 dividend on an annualized basis and a yield of 0.8%. This is a positive change from Danaher’s previous quarterly dividend of $0.32. Danaher’s dividend payout ratio (DPR) is 31.75%.

Insider Buying and Selling

In related news, EVP Gregory M. Milosevich sold 1,320 shares of the firm’s stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $208.01, for a total value of $274,573.20. Following the completion of the transaction, the executive vice president owned 5,099 shares of the company’s stock, valued at approximately $1,060,642.99. This trade represents a 20.56% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 10.80% of the company’s stock.

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.